Virtual Reality-Enabled Digital Storytelling

NCT ID: NCT07167030

Last Updated: 2025-09-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

112 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-11-01

Study Completion Date

2026-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Current scientific literature on VR details primarily focuses on fear and anxiety during childbirth. Variables such as attachment, fear, and self-efficacy are often considered independently. Therefore, in addition to interventions focused on the prenatal period, a need arose for holistic audiovisual and technologically supported intervention models that simultaneously address multidimensional aspects of life, such as prenatal attachment, fear of childbirth, and perception of childbirth self-efficacy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a randomized controlled trial conducted to evaluate the effects of digital storytelling applied to primiparous pregnant women via virtual reality glasses on prenatal attachment, fear of childbirth, perception of childbirth self-efficacy, and non-stress test results. The study will consist of two groups: an experimental and a control group. Participants in the experimental group will access a digital storytelling training program via virtual reality glasses and receive information and guidance on topics such as prenatal attachment, fear of childbirth, and perception of childbirth self-efficacy. Participants in the control group will receive standard care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primiparous Pregnant Women

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Arm 1 Intervention Arm: Participants in the intervention group will receive digital storytelling modules using virtual reality (VR) headsets once a week for four weeks, starting at 28 weeks of gestation. Each module will include three topics (2-10 minutes). After each topic, there will be a rest period followed by an interactive session. The final two modules will be administered during the NST recording, and mother and baby status will be monitored. Each module, including the interactive session, will last 45-50 minutes. Participants will receive an educational brochure after the module and will be reminded via WhatsApp.

Arm 2 Control Arm: Participants in the control group will receive routine care.

Posttests (at the end of 36 weeks of gestation):

* Prenatal Attachment Inventory
* Wijma Birth Expectations/Experiences Questionnaire Version A
* Short Version of the Labor Self-Efficacy Scale
* Satisfaction Level Information Form for the VR Headset Application
* NST Follow-up Form
* Video
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants
There is no other hidden side to this study.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

İntervention Arm

Participants in the intervention group will receive digital storytelling modules using virtual reality (VR) headsets once a week for four weeks, starting at 28 weeks of gestation. Each module will include three topics (2-10 minutes). After each topic, there will be a rest period followed by an interactive session. The final two modules will be administered during the NST recording, and mother and baby status will be monitored. Each module, including the interactive session, will last 45-50 minutes. Participants will receive an educational brochure after the module and will be reminded via WhatsApp.

Posttests (at the end of 36 weeks of gestation):

* Prenatal Attachment Inventory
* Wijma Birth Expectations/Experiences Questionnaire Version A
* Short Version of the Labor Self-Efficacy Scale
* Satisfaction Level Information Form for the VR Headset Application
* NST Follow-up Form
* Video Immersion Scale

Group Type EXPERIMENTAL

Virtual Reality Digital Storytelling

Intervention Type BEHAVIORAL

Participants in the intervention group will receive digital storytelling modules using virtual reality (VR) headsets once a week for four weeks, starting at 28 weeks of gestation. Each module will include three topics (2-10 minutes). After each topic, there will be a rest period followed by an interactive session. The final two modules will be administered during the NST recording, and mother and baby status will be monitored. Each module, including the interactive session, will last 45-50 minutes. Participants will receive an educational brochure after the module and will be reminded via WhatsApp.

Control Arm

Participants in the control group will receive routine care.

Posttests (at the end of 36 weeks of gestation):

* Prenatal Attachment Inventory
* Wijma Birth Expectations/Experiences Questionnaire Version A
* Short Version of the Labor Self-Efficacy Scale
* NST Follow-up Form

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual Reality Digital Storytelling

Participants in the intervention group will receive digital storytelling modules using virtual reality (VR) headsets once a week for four weeks, starting at 28 weeks of gestation. Each module will include three topics (2-10 minutes). After each topic, there will be a rest period followed by an interactive session. The final two modules will be administered during the NST recording, and mother and baby status will be monitored. Each module, including the interactive session, will last 45-50 minutes. Participants will receive an educational brochure after the module and will be reminded via WhatsApp.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primiparous women in their 28th week of pregnancy
* Between the ages of 18 and 40
* Experiencing a singleton pregnancy
* Applied to the Yozgat City Hospital Gynecology and Obstetrics Clinic and agreed to participate in the study
* Have a primary school education and can understand Turkish
* Have no serious vision or balance problems that would prevent the use of VR glasses
* Have not experienced any risky pregnancy problems (premature membrane rupture, preeclampsia, gestational diabetes, etc.)
* Have no identified fetal anomalies
* Have no psychiatric diagnosis

Exclusion Criteria

* Pregnant women who cannot obtain a work permit and who do not agree to participate in the study will not be included in the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bozok University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

RUKİYE DİKMEN

Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

RUKİYE DİKMEN, PhD Student

Role: CONTACT

+905433686510

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1231

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.